首页> 外文期刊>Antimicrobial agents and chemotherapy. >Gastrointestinal colonization with a cephalosporinase-producing Bacteroides species preserves colonization resistance against vancomycin-resistant Enterococcus and Clostridium difficile in cephalosporin-treated mice
【24h】

Gastrointestinal colonization with a cephalosporinase-producing Bacteroides species preserves colonization resistance against vancomycin-resistant Enterococcus and Clostridium difficile in cephalosporin-treated mice

机译:在头孢菌素治疗的小鼠中,产生头孢菌素酶的拟杆菌属菌种在胃肠道中的定殖保留了对耐万古霉素肠球菌和艰难梭菌的定殖性

获取原文
获取原文并翻译 | 示例
       

摘要

Antibiotics that are excreted into the intestinal tract may disrupt the indigenous intestinal microbiota and promote colonization by health care-associated pathogens. β-Lactam, or penicillin-type, antibiotics are among the most widely utilized antibiotics worldwide and may also adversely affect the microbiota. Many bacteria are capable, however, of producing β-lactamase enzymes that inactivate β-lactam antibiotics. We hypothesized that prior establishment of intestinal colonization with a β-lactamaseproducing anaerobe might prevent these adverse effects of β-lactam antibiotics, by inactivating the portion of antibiotic that is excreted into the intestinal tract. Here, mice with a previously abolished microbiota received either oral normal saline or an oral cephalosporinase- producing strain of Bacteroides thetaiotaomicron for 3 days. Mice then received 3 days of subcutaneous ceftriaxone, followed by either oral administration of vancomycin-resistant Enterococcus (VRE) or sacrifice and assessment of in vitro growth of epidemic and nonepidemic strains of Clostridium difficile in murine cecal contents. Stool concentrations of VRE and ceftriaxone were measured, cecal levels of C. difficile 24 h after incubation were quantified, and denaturing gradient gel electrophoresis (DGGE) of microbial 16S rRNA genes was performed to evaluate the antibiotic effect on the microbiota. The results demonstrated that establishment of prior colonization with a β-lactamase-producing intestinal anaerobe inactivated intraintestinal ceftriaxone during treatment with this antibiotic, allowed recovery of the normal microbiota despite systemic ceftriaxone, and prevented overgrowth with VRE and epidemic and nonepidemic strains of C. difficile in mice. These findings describe a novel probiotic strategy to potentially prevent pathogen colonization in hospitalized patients.
机译:排入肠道的抗生素可能会破坏本地肠道菌群,并促进与卫生保健相关的病原体的定殖。 β-内酰胺或青霉素类抗生素是全球使用最广泛的抗生素之一,也可能对微生物群产生不利影响。然而,许多细菌能够产生使β-内酰胺抗生素失活的β-内酰胺酶。我们假设事先通过产生β-内酰胺酶的厌氧菌建立肠道菌落可能通过使排泄到肠道的部分抗生素失活来预防β-内酰胺类抗生素的这些不利影响。在这里,先前已被消灭的微生物群的小鼠接受了口服生理盐水或口服产头孢菌素酶的拟杆菌(Bacteroides thetaiotaomicron)菌株3天。然后将小鼠皮下注射头孢曲松3天,然后口服给予耐万古霉素的肠球菌(VRE)或处死并评估鼠盲肠内容物中艰难梭菌的流行和非流行菌株的体外生长。测量粪便中VRE和头孢曲松的浓度,孵育24小时后测定盲肠艰难梭菌的盲肠水平,并对微生物16S rRNA基因进行变性梯度凝胶电泳(DGGE),以评估抗生素对微生物的影响。结果表明,在用这种抗生素治疗期间,先用产生β-内酰胺酶的肠道厌氧菌灭活的肠内头孢曲松定殖,既使全身性头孢曲松也能恢复正常菌群,并防止VRE和艰难梭菌流行和非流行菌株的过度生长。在小鼠中。这些发现描述了一种新型的益生菌策略,可潜在地预防住院患者中的病原体定植。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号